The role of DNA methylation in ovarian cancer chemoresistance: A narrative review.
Song K. and Artibani M., (2023), Health Sci Rep, 6
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells
Artibani M. et al, (2021), JCI Insight
Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct
Santana Gonzalez L. et al, (2021), Frontiers in Cellular and Infection Microbiology
Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct
Santana Gonzalez L. et al, (2021), Frontiers in Cell and Developmental Biology
Promises and challenges of adoptive T-cell therapies for solid tumours
AHMED A. et al, (2021), British Journal of Cancer
Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct.
Santana Gonzalez L. et al, (2021), Front Cell Dev Biol, 9
A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes.
KaramiNejadRanjbar M. et al, (2020), Elife, 9
Enhanced immunogenicity of mitochondrial localised proteins in cancer cells
CERUNDOLO V. et al, (2020), Cancer Immunology Research
An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.
Motohara T. et al, (2019), Oncogene, 38, 2885 - 2898
WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer.
McGregor RJ. et al, (2018), Br J Cancer, 119, 1508 - 1517
The Oxford Ovarian Cancer Predict Chemotherapy Response (OXO-PCR) study: Understanding the genomic drivers of primary chemotherapy-resistant microscopic residual disease
Artibani M. et al, (2018), CANCER RESEARCH, 78